Two years ago, Stahl suffering from osteoarthritis signed up to participate in trials of a new painkiller from Merck & Co. The treatment eased the pain and stiffness without upsetting his stomach, as some other medicines had. The drug is one of a potentially revolutionary new class of painkillers that addresses the agony of the 40 million Americans with arthritis and countless more with other painful ailments.